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Neurotrophin-3 and other neurotrophic factors con- 
tribute to the development and maintenance of the ver- 
tebrate nervous system by promoting localized neuro- 
nal survival. The human gene encoding neurotrophin- 
3, a highly conserved protein with complete amino 
acid identity in human, mouse, and rat, has been 
mapped to Chromosome (Chr) 12p13 (Maisonpierre et 
al. 1991). The mouse homolog, Ntf-3, was assigned to 
Chr 6 by use of a somatic cell panel (Ozcelik et al. 
1991). We undertook the regional localization of Ntf-3 
in order to test it as a candidate for the mnd2 mutation 
which we recently mapped to Chr 6; homozygosity for 
mnd2 results in motor neuron disease due to degener- 
ation of spinal motor neurons (Jones et al. 1993). 
von Willebrand factor is a glycoprotein involved in 
blood coagulation that is both a carrier for factor VIII 
(antihemophilic factor) and a mediator of platelet- 
vessel wall interaction (Ginsburg and Bowie 1992). 
The human gene VWF (previous symbol F8VWF) is 
the most  distally mapped gene on Chr 12p13.3 
(NIH/CEPH Collaborative Mapping Group 1992). The 
locations of NTF3 and VWF suggested that they might 
be members of the conserved linkage group on mouse 
Chr 6 that includes 11 other genes from human 12p12- 
13 (Nadeau et al. 1992; Elliott and Moore 1992). 
Ntf-3 was mapped by Southern blot analysis with a 
BgllI RFLP between strains C57BL/6J (3.6 kb) and 
SPRET/Ei (9.7 kb; Fig. 1). The Ntf-3 probe was a 550- 
bp genomic fragment that was amplified from genomic 
DNA from strain C57BL/6J with primers based on the 
published nucleotide sequence (Hohn et at. 1990): 
primer 1, 5' (+250) AGG AGT TTG CCG GAA GAC 
TCT CTC AAT TCC (+279) 3'; and primer 2, 5' 
(+ 799) GCA ACC GTT TTT GAC CGG CCT GGC 
Correspondence to: M.H. Meisler 
TTC (+ 772) 3'. Amplification was carried out for 30 
cycles with 1 min at 94~ and 1 min at 72~ 
Two PCR-based genetic variants were used to map 
the Vwf locus. First, a length polymorphism between 
C57BL/6J (115 bp) and CAST/Ei (119 bp) was detected 
by direct amplification of 0.2 txg of genomic DNA with 
primer 3 (5' TCC GGT GCC TTA CAG TCT GCT G 
3') and primer 4 (5' TGT ACT CAG TAG TTC TTC 
CTA GGA G 3'). Primer 3 was end-labeled with ~/32p_ 
ATP (>5000 Ci/mmol, Amersham) by use of polynu- 
cleotide kinase (New England Biolabs) as previously 
described (Roth et al. 1990). Amplification was carried 
out for 30 cycles with 1 min at 94~ 30 s at 60~ and 
30 s at 72~ PCR products were diluted threefold with 
formamide loading buffer and electrophoresed on 8% 
denaturing polyacrylamide gels. Second, a PCR RFLP 
between C57BL/6J and SPRET/Ei was detected by 
amplification of 0.2 Ixg of genomic DNA with primer 5 
from exon 28 (5' CCT TCA ATG GAT CCC AGT CCA 
AGG AGG AGG 3') and primer 6 from intron 28 (5'- 
GTT CTA GAC TCA AGC TTC TGG ATC TGT GTG 
3') in a 50-~1 reaction under previously described con- 
ditions (Ginsburg et al. 1989). Amplification was car- 
ried out for 35 cycles of 1 min at 94~ 30 s at 55~ and 
2 min at 72~ The PCR products were then digested 
with RsaI and analyzed on a 4% agarose gel containing 
3% FMC NuSieve and 1% BRL agarose (Fig. 1; 
Nichols et al., manuscript in preparation). 
Ntf-3 and Vwfwere mapped with respect to the Chr 
6 reference loci mi and Raf-1, as well as several anon- 
ymous DNA markers. Microophthalmia (mi) was 
typed by hybridization with the 2.5-kb genomic clone 
p24RI2.5, which directly flanks the insertion site of a 
transgenic insertional mutation at this locus (Kra- 
kowsky et al. 1993). This probe hybridizes with Hin- 
dIII fragments of 4.5 kb in C57BL/6J and 3.9 kb in 
SPRET/Ei (Fig. 1). A TaqI polymorphism (Jones et al. 
1993) at the anchor locus Raf-1 (Kozak et al. 1984) was 
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Fig. 1. Genetic variation at three loci on Chr 6. For Southern blot 
analysis of Ntf-3 and mi, genomic DNA was digested with BglII and 
HindIII, respectively, and hybridized as described below. The po- 
sitions of bacteriophage X HindIII fragments are indicated (kb). For 
analysis of Vwf, genomic DNA was amplified by PCR, followed by 
digestion with RsaI as described in the text. A heteroduplex band is 
visible in heterozygous samples (solid circle). The positions of 
qbX174 HaeIII fragments are indicated (bp). B, C57BL/6J; S, 
SPRET/Ei; l ,  heterozygous backcross individual; 2, homozygous 
backcross individual. Methods. Genomic DNA was extracted by a 
salting out procedure (Miller et al. 1988), digested overnight with the 
appropriate restriction enzymes, and electrophoresed on 0.7% aga- 
rose gels with 10 ~g DNA per lane. DNA fragments were transferred 
to Zetaprobe GT (Bio-Rad Laboratories) nylon filters by capillary 
blotting (Southern 1975) and hybridized for 18 h at 65 ~ in 20 ml of 
hybridization solution (0.5 M dibasic sodium phosphate, 1 mM 
EDTA, 7% SDS, pH 7.2) with a final wash of 0.1 • SSC, 0.1% SDS 
at 65~ before the filters were exposed to X-ray film for 2-4 days. 
Probes were labeled with ctaEp-dCTP (>3000 Ci/mmol, Amersham) 
by random oligoprimed labeling to 10 9 cpm/~g (Feinberg and Vo- 
gelstein 1983). 
detected by hybridization with the probe p627 (ATCC 
No. 41050). Primers for the microsatellite markers 
D6Mit8, D6Mitll, D6Mit12, and D6Mitl4 were ob- 
tained from Research Genetics (Huntsville, Ala.). 
PCR analysis was carried out as described (Dietrich et 
al. 1992) except that 100 ng of template DNA was 
used, and pfiiducts were labeled by incorporation of 
a32p-dCTP (>3000 Ci/mmol, Amersham) (1 ~Ci per 
10-1xl reaction) with a 40-fold reduction of unlabeled 
dCTP in the reactions. 
Vwf was first mapped on a previously described 
(C57BL/6J-mnd2 x CAST/Ei)F2 mapping panel com- 
prised of individuals homozygous for the Chr 6 muta- 
tion mnd2 (Jones et al. 1993). Haplotypes from this 
panel are presented in Fig. 2A. The data localize Vwf 
to the interval between Raf-1 and D6Mitl4, with the 
indicated gene order: (centromere)-D6Mit8-(12.5 +-- 
4.8)-Raf-1, D6Mitll-(2.1 +- 2.1)-Vwf, D6Mit12-(lO.4 
+_ 4.4)-D6Mit14. Additional loci including Ntf-3 were 
analyzed on a backcross between C57BL/6J-tg9257 
and SPRET/Ei (Bain et al. 1993). Again, there were no 
recombinants between Vwf and D6Mitl2 (Fig. 2B). 
The results demonstrate the gene order: (centromere)- 
D6Mit8-(7.5 +- 3.6)-mi-(9.4 -+ 4.0)-Vwf, D6Mit12-(1.9 
+- 1.9)-Ntf-3. 
The results of the two crosses are combined in the 
map in Fig. 3, demonstrating gene order and relative 
positions of these loci. The positions of mi and Raf-1 
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Fig. 2. Linkage data for loci on Chr 6. (A) Haplotypes from 
(C57BL/6J-mnd2 x CAST/Ei) F 2 animals. (B) Tierred mapping of 
b a c k c r o s s  p r o g e n y  f rom the  c ross  (C57BL/6J - tg9257  x 
SPRET/Ei)FI x C57BL/6J. Each column represents one haplotype, 
and the number of mice with each haplotype is given at the bottom 
of each column. All of the F 2 progeny typed were homozygous for 
the Chr 6 locus mnd2 (Jones et al. 1993); haplotypes were inferred 
by assuming the absence of double crossovers between markers in 
this 20 CM region. Solid symbols, C57BL/6J homozygotes; open sym- 
bols, heterozygotes with C57BL/6J and CAST/Ei or SPRET/Ei al- 
leles. 
are consistent with the Chromosome 6 Committee map 
(Elliott and Moore 1992). Since mnd2 is located prox- 
imal to Raf-1 (Jones et al. 1993), the data eliminate 
Ntf-3 as a candidate gene for this disorder. Ntf-3 may 
be considered a candidate for the mutation opisthoto- 
nus, which maps to this region and results in loss of 
balance and early death (Green 1989; Elliott and 
Moore 1992). 
Our data add two new loci to the conserved linkage 
group on human Chr 12p12-13 and mouse Chr 6 
(Nadeau et al. 1992; Elliott and Moore 1992). It is in- 
teresting that the von Willebrand factor gene is located 
close to the telomere on human Chr 12 but at an in- 
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Fig. 3. Order of Chr 6 loci based on data in Fig. 2. The approximate 
map positions are indicated in cM from the centromere (Elliott and 
Moore 1992). The positions of human genes homologous to the un- 
derlined mouse loci are indicated at the right (Bonnet et al. 1984; 
NIH/CEPH Collaborative Mapping Group 1992; Maisonpierre et al. 
1991). 
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additional mammalian species would be of interest 
with regard to evolution of the 12p telomere. The lo- 
calization of Vwf reported here will facilitate ongoing 
investigations of clotting disorders in the mouse, in- 
cluding characterization of a mouse model for von 
Willebrand disease (Sweeney et al. 1990). There are no 
known clotting mutations in this region of Chr 6. 
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